رجوع
48
48
مُدرج أيضًا باسم
GNGBY
OTC
نطاق اليوم
KWD 23.23
KWD 23.23
نطاق 52 أسبوعًا
KWD 18.82
KWD 24.75
حجم التداول
200
متوسط 50 يوم / 200 يوم
KWD 22.92
/
KWD 21.43
الإغلاق السابق
KWD 23.23
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 2.6 | 0.4 |
| P/B | 0.2 | 2.9 |
| ROE % | 7.2 | 3.8 |
| Net Margin % | 6.5 | 3.9 |
| Rev Growth 5Y % | 6.6 | 10.0 |
| D/E | 0.4 | 0.2 |
النقاط الرئيسية
Revenue grew 6.63% annually over 5 years — modest growth
Earnings grew 37.85% over the past year
Debt/Equity of 0.37 — conservative balance sheet
Generating 2.64B in free cash flow
P/E of 2.61 — trading at a low valuation
PEG of 0.65 suggests growth is underpriced
النمو
Revenue Growth (5Y)
6.63%
Revenue (1Y)0.60%
Earnings (1Y)37.85%
FCF Growth (3Y)28.17%
الجودة
Return on Equity
7.23%
ROIC7.79%
Net Margin6.46%
Op. Margin11.97%
الأمان
Debt / Equity
0.37
Current Ratio1.32
Interest Coverage6.52
التقييم
P/E Ratio
2.61
P/B Ratio0.20
EV/EBITDA3.20
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0.60% | Revenue Growth (3Y) | 4.82% |
| Earnings Growth (1Y) | 37.85% | Earnings Growth (3Y) | -3.25% |
| Revenue Growth (5Y) | 6.63% | Earnings Growth (5Y) | -6.62% |
| Profitability | |||
| Revenue (TTM) | 34.97B | Net Income (TTM) | 2.26B |
| ROE | 7.23% | ROA | 4.00% |
| Gross Margin | 44.34% | Operating Margin | 11.97% |
| Net Margin | 6.46% | Free Cash Flow (TTM) | 2.64B |
| ROIC | 7.79% | FCF Growth (3Y) | 28.17% |
| Safety | |||
| Debt / Equity | 0.37 | Current Ratio | 1.32 |
| Interest Coverage | 6.52 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 2.61 | P/B Ratio | 0.20 |
| P/S Ratio | 0.17 | PEG Ratio | 0.65 |
| EV/EBITDA | 3.20 | Dividend Yield | 0.02% |
| Market Cap | 5.90B | Enterprise Value | 13.39B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 34.97B | 34.76B | 31.83B | 28.29B | 27.05B |
| Net Income | 2.26B | 1.64B | 2.41B | 2.49B | 2.97B |
| EPS (Diluted) | 8.29 | 6.01 | 8.86 | 9.15 | 10.90 |
| Gross Profit | 15.51B | 16.15B | 14.50B | 13.41B | 13.58B |
| Operating Income | 4.19B | 2.85B | 3.74B | 3.63B | 4.37B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 56.51B | 63.92B | 53.59B | 52.03B | 44.56B |
| Total Liabilities | 27.01B | 30.71B | 23.18B | 21.58B | 19.38B |
| Shareholders' Equity | 29.43B | 33.01B | 30.17B | 30.04B | 24.75B |
| Total Debt | 10.88B | 10.73B | 8.08B | 5.82B | 4.31B |
| Cash & Equivalents | 3.40B | 2.96B | 2.73B | 5.68B | 4.08B |
| Current Assets | 17.23B | 18.16B | 16.65B | 19.11B | 15.07B |
| Current Liabilities | 13.04B | 15.05B | 13.19B | 11.99B | 10.61B |
درجات الاستراتيجيات
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#319 of 820
#147 of 708
النشاط الأخير
دخل
Deep Value Investing (Seth Klarman)
Mar 24, 2026
دخل
Defensive Investing (Benjamin Graham)
Mar 24, 2026